The H-Investments Team
UK will dominate next-generation mRNA drug delivery worldwide
London, UK, 4 October 2023 - A new report by the BioIndustry Association (BIA) reveals how the UK is poised to become a global leader in mRNA medicine, an emerging technology that rose to prominence during the COVID pandemic but has vast potential beyond. The importance of this technology has
The acquisition of multi-kilogram GMP and fill-finish capability supports product discovery to commercialization.
Staad, September 25 2023 – Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic peptides with multi-kilogram GMP facilities and fill-finish capabilities designed to support customers from clinical trials to commercial supply. Dr. Urs Spitz, CEO
The Cell Therapy Manufacturing Center automates, closes, and scales using ScaleReady for patient access.
St. Paul, MN and Houston, TX, US, October 4, 2023 — ScaleReady, the cell therapy manufacturing solutions expert, and CTMC, a joint venture between National Resilience Inc. and MD Anderson Cancer Center, today announces a collaborative partnership to help lessen the manufacturing barriers holding back life-saving cell and gene therapies from
Biosynth Strengthens Position in Peptide Field through Pepceuticals Acquisition
Biosynth has further strengthened its peptide division with the acquisition of Pepceuticals. Swiss headquartered critical materials supplier, Biosynth, has announced its acquisition of a British manufacturer of synthetic peptides, Pepceuticals, in a Sep. 25, 2023 press release, bolstering its position within the peptide market. Through this acquisition, Biosynth will gain
CTMC Partners with ScaleReady for Combatting Manufacturing Barriers
The agreement will enable CTMC to strategically scale the recently completed good manufacturing practice facility to drive high-throughput manufacturing utilizing the automated, closed system capabilities of the Fresenius Kabi Lovo and Cue cell processing systems. ScaleReady and CTMC have announced a partnership as of Oct. 4, 2023, to help lessen
FDA Establishes Pilot Program to Accelerate Rare Disease Therapy Development
The program will allow sponsors of certain CBER and/or CDER-regulated products more frequent communication with FDA staff. On Sept 29, 2023, the FDA announced a pilot program, Support for Clinical Trials Advancing Rare Disease Therapeutics (START), intended to support the development of novel drugs and biological products for rare
Lilly to Acquire POINT Biopharma
POINT is a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies in development for the treatment of cancer. *Editor's note: the story has been updated to include financial terms. Eli Lilly and Company (Lilly) and POINT Biopharma Global (POINT) announced on Oct. 3, 2023, a
Sharp Acquires Berkshire Sterile Manufacturing
With the acquisition, Sharp plans on offering fully integrated small-to-medium-scale sterile injectable services. Sharp, a packaging and clinical trial supply services company, announced on Oct. 5, 2023, the acquisition of Berkshire Sterile Manufacturing (BSM), a contract development and manufacturing organization (CDMO) located in Massachusetts that offers clinical and commercial sterile
Kyowa Kirin Set to Acquire Orchard Therapeutics for $477.6 million
The Japanese biotech company plans to make good use of Orchard’s portfolio, furthering its goal of providing life-changing medical care through cell and gene therapy. On Oct. 5, 2023, Kyowa Kirin Co, a biotechnological pharmaceutical company based in Japan, announced that it plans to acquire Orchard Therapeutics, a “global
Pfizer and Ginkgo Bioworks to Collaborate on Multi-Target RNA Discovery
Pfizer has entered into a collaboration with Ginkgo Bioworks to discover novel RNA molecules across priority research areas. Ginkgo Bioworks announced a collaboration on Sept. 27, 2023, with Pfizer under which Pfizer will use Ginkgo's proprietary RNA technology to advance the discovery and development of novel RNA molecules
Particle Measuring Systems Announce Acquisition of Environmental Monitoring Services Limited and EMS Particle Solutions
EMS is a leader in the cleanroom industry, delivering complete cleanroom monitoring and control solutions, and services to customers, and ensuring quality by design from inception to process control. Particle Measuring Systems Inc. announced the acquisition of Environmental Monitoring Services and EMS Particle Solutions and their parent company on Oct.